Events

Device Recall NEXGEN POROUS, HA/TCP, UNCEMENTED FEMORAL AND TIBIAL BASEPLATE COMPONENTS 의 리콜

U.S. Food and Drug Administration에 따르면, 해당 리콜 는 United States 에서 Zimmer Biomet, Inc. 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 사례 ID
    78706
  • 사례 위험등급
    Class 2
  • 사례 연번
    Z-1031-2018
  • 사례 시작날짜
    2017-11-29
  • 사례 상황
    Open, Classified
  • 사례 국가
    United States
  • 사례 출처
    USFDA
  • 사례 출처 URL
    https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=160190
  • 비고 / 경고
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • 데이터 추가 비고
    Prosthesis, knee, patello/femorotibial, semi-constrained, uncemented, porous, coated, polymer/metal/polymer - Product Code MBH
  • 원인
    The ldpe bag packaging for various highly polished hip and knee implants may adhere to the highly polished surface, leaving residue or material from the ldpe bag on the implant after it is removed from the bag.
  • 조치
    A similar recall was initiated in January 2016 to remove remaining inventory packaged in the old bag. Further evaluation identified additional lots packaged in the old bag that were not included in the January 2016 recall; therefore, resulting in this new recall for the additional lots packaged in the old bag. A firm, Zimmer Biomet, sent an "Urgent Medical Device Recall" notices dated November 29, 2017 and response forms to customers. The notice described the product, problem and actions to be taken. The Customers should take the following action: Risk Manager Responsibilities: 1. Review this notification and ensure that affected personnel are aware of the contents. 2. If you have affected product at your facility, assist your Zimmer Biomet sales representative and quarantine all affected product. Your Zimmer Biomet sales representative will remove the affected product from your facility. 3. Complete Attachment 1  Certificate of Acknowledgement and send to CorporateQuality.PostMarket@zimmerbiomet.com. This form must be returned even if you do not have affected products at your facility. 4. Retain a copy of the acknowledgement form with your recall records in the event of a compliance audit of your facilitys documentation. Distributor Responsibilities: 1. Review this notification and ensure that affected team members are aware of the contents. 2. Immediately locate and quarantine affected product in your inventory. 3. Immediately return all affected product from your distributorship and from affected hospitals within your territory. a. Complete Attachment 1  Inventory Return Certification Form and send to CorporateQuality.PostMarket@zimmerbiomet.com within three (3) days. b. For each return, send a copy of Attachment 1 to CorporateQuality.PostMarket@zimmerbiomet.com. c. Include a hardcopy of Attachment 1 in each carton of your return shipment for immediate processing. d. Mark RECALL on the outside of the returned cartons. 4. Return the Additi

Device

Device Recall NEXGEN POROUS, HA/TCP, UNCEMENTED FEMORAL AND TIBIAL BASEPLATE COMPONENTS
  • 모델명 / 제조번호(시리얼번호)
    65-5952-013-05 61819644 65-5952-013-05 61855471 65-5952-013-05 11004433 65-5952-013-06 62056868 65-5952-014-05 61782591 65-5952-014-05 11003623 65-5952-014-05 61987912 65-5952-014-05 62104150 65-5952-014-06 61835232 65-5952-014-06 62038826 65-5952-014-06 62132128 65-5952-015-05 61782592 65-5952-015-05 61822359 65-5952-015-05 61857405 65-5952-015-05 11004436 65-5952-015-05 61939607 65-5952-015-05 62020177 65-5952-015-05 62046101 65-5952-015-05 62122758 65-5952-015-06 61805662 65-5952-015-06 11003505 65-5952-015-06 61848476 65-5952-015-06 11004261 65-5952-015-06 61921288 65-5952-015-06 61968654 65-5952-015-06 62001382 65-5952-015-06 62025672 65-5952-015-06 62074886 65-5952-015-06 62128161 65-5952-016-05 61801433 65-5952-016-05 61836563 65-5952-016-05 61857407 65-5952-016-05 11004258 65-5952-016-05 11004438 65-5952-016-05 61928636 65-5952-016-05 61951539 65-5952-016-05 62020178 65-5952-016-05 62056869 65-5952-016-05 62092424 65-5952-016-05 62139313 65-5952-016-06 61777547 65-5952-016-06 61822354 65-5952-016-06 61857408 65-5952-016-06 11004434 65-5952-016-06 61904112 65-5952-016-06 61939609 65-5952-016-06 62002454 65-5952-016-06 62020219 65-5952-016-06 62062056 65-5952-016-06 62104151 65-5952-017-05 61824510 65-5952-017-05 61893908 65-5952-017-05 61939612 65-5952-017-05 62005729 65-5952-017-05 62025675 65-5952-017-05 62086012 65-5952-017-05 62132131 65-5952-017-06 11003018 65-5952-017-06 61795937 65-5952-017-06 61822355 65-5952-017-06 11003671 65-5952-017-06 61861698 65-5952-017-06 61846121 65-5952-017-06 11004260 65-5952-017-06 61915980 65-5952-017-06 61987914 65-5952-017-06 62020182 65-5952-017-06 62038827 65-5952-017-06 62105368
  • 의료기기 분류등급
    Orthopedic Devices
  • 의료기기 등급
    2
  • 이식된 장치?
    Yes
  • 유통
    Worldwide Distribution: US (nationwide) and countries of: Argentina, Australia, Brazil, Bolivia, Canada, Chile, China, Colombia, Ecuador, El Salvador, India, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nicaragua, Panama, Seoul-Korea, Singapore, Taiwan, Thailand, and UAE.
  • 제품 설명
    CR-FLX POR HATCP FEM C-L MINUS || CR-FLX POR HATCP FEM C-R MINUS || CR-FLX POR HATCP FEM D-L MINUS || CR-FLX POR HATCP FEM D-R MINUS || CR-FLX POR HATCP FEM E-L MINUS || CR-FLX POR HATCP FEM E-R MINUS || CR-FLX POR HATCP FEM F-L MINUS || CR-FLX POR HATCP FEM F-R MINUS || CR-FLX POR HATCP FEM G-L MINUS || CR-FLX POR HATCP FEM G-R MINUS || This device is indicated for patients with severe knee pain and disability
  • Manufacturer
    Zimmer Biomet, Inc.

Manufacturer

Zimmer Biomet, Inc.
  • 제조사 주소
    Zimmer Biomet, Inc., 1800 W Center St, Warsaw IN 46580-2304
  • 제조사 모회사 (2017)
    Zimmer Biomet Holdings
  • 제조사 의견
    “The safety of patients has always been, and continues to be, Zimmer Biomet’s top priority and it is our honor to be a leader in this industry for the past 90 years,” Zimmer Biomet told ICIJ in a statement. “We adhere to strict regulatory standards, and work closely with the FDA and all applicable regulatory agencies in each of our regions as part of our commitment to operating a first-rate quality management system across our global manufacturing network. The company added that it is focused on staying at the forefront of innovation and doing right by the millions of patients who rely on the company’s products.
  • Source
    USFDA